Cargando…

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common gastrointestinal malignancies. It is not easy to be diagnosed in the early stage and is prone to relapse, with a very poor prognosis. And immune cell infiltration and tumor microenvironment play important roles in predicting therapeutic respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lei, Chen, Guojie, Liu, Tao, Liu, Xinyuan, Yang, Chengxiao, Jiang, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500549/ https://www.ncbi.nlm.nih.gov/pubmed/36159990 http://dx.doi.org/10.3389/fgene.2022.965805

Ejemplares similares

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma
por: Pan, Chenxi, et al.
Publicado: (2022)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

NAP1L1 Functions as a Novel Prognostic Biomarker Associated With Macrophages and Promotes Tumor Progression by Influencing the Wnt/β-Catenin Pathway in Hepatocellular Carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma
por: Zheng, Susu, et al.
Publicado: (2021)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2022)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment
por: Liu, Shanshan, et al.
Publicado: (2021)

Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma
por: Qin, Jiangfeng, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Fan, Yumei, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
por: Pu, Zhangya, et al.
Publicado: (2021)

Phosphatidylinositol glycan anchor biosynthesis, class C is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Zhao, Qian, et al.
Publicado: (2022)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration
por: Peng, Qing, et al.
Publicado: (2022)

DNAJ heat shock protein family member C1 can regulate proliferation and migration in hepatocellular carcinoma
por: Fan, Yu-Chun, et al.
Publicado: (2023)

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer
por: Gao, Wen-Liang, et al.
Publicado: (2022)

Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
por: Wang, Wei, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data
por: Zhu, Changyu, et al.
Publicado: (2022)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma
por: Wang, Dong, et al.
Publicado: (2022)

Analyzing Roles of NUSAP1 From Clinical, Molecular Mechanism and Immune Perspectives in Hepatocellular Carcinoma
por: Zhu, Wenjie, et al.
Publicado: (2021)

YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2021)

The Role of Early Growth Response Family Members 1–4 in Prognostic Value of Breast Cancer
por: Hao, Leiyu, et al.
Publicado: (2021)

Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Yan, Yan, et al.
Publicado: (2022)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma
por: Rao, Jiawei, et al.
Publicado: (2020)

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
por: Wang, Wen-Jie, et al.
Publicado: (2020)

KLF4 loss in hepatocellular carcinoma: Improving prognostic prediction and correlating immune infiltrates
por: Chen, Desheng, et al.
Publicado: (2023)

Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
por: Zhao, Qianwei, et al.
Publicado: (2020)

Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
por: Ma, Keqiang, et al.
Publicado: (2023)

Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers
por: Wang, Hengzhen, et al.
Publicado: (2021)

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer
por: Li, Dingchang, et al.
Publicado: (2022)

Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma
por: Liang, Tao-tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nub76692c6vedq8as35pmfgm60